Skip to main contentSkip to navigation
Sirius Investors
Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc.

IPCIF
OTCHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for IPCIF. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
2.32M
-99.64% over period
CAGR: -19.46%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
4.56M
-99.29% over period
CAGR: -17.31%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Aug 31, 2023

EV/EBITDA

Distorted

-2.56x

Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.

EV vs Market Cap Spread

2.24M

EV is +96.8% vs equity value

Capital Structure Signal

Net Debt Profile

EV premium trend: +97.4 pp vs earliest data

Additional Multiples

EV/Sales: 64.98x

Net Debt/EBITDA: -1.04x

Share count change in dataset: +156.64%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Nov 30, 20222.32M4.56M$0.0733.09M
Nov 30, 20213.53M5.77M$0.1229.43M
Nov 30, 20203.06M4.21M$0.1323.56M
Nov 30, 2019
Nov 30, 2018
Nov 30, 2017
Nov 30, 2016
Nov 30, 2015
Nov 30, 2014
Nov 30, 2013
Nov 30, 2012
Nov 30, 2011
Nov 30, 2010
Nov 30, 2009
Nov 30, 2008
Nov 30, 2007
Nov 30, 2006
Nov 30, 2005
Nov 30, 2004
Nov 30, 2003
Nov 30, 2002
Nov 30, 2001
Nov 30, 2000
Nov 30, 1999
Nov 30, 1998
Nov 30, 1997
Nov 30, 1996

Enterprise Value Analysis

Price Change (Nov 2021 to Nov 2022)

The stock price has decreased from Nov 2021 to Nov 2022.
-41.67%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
0.19

Risk-Adjusted Return

The stock's returns do not compensate for its risk level, suggesting a poor risk-reward profile.
-1.51

Market Cap Change (Nov 2021 to Nov 2022)

The company's market capitalization has decreased from Nov 2021 to Nov 2022.
-34.41%

Enterprise Value Change (Nov 2021 to Nov 2022)

The company's enterprise value has decreased from Nov 2021 to Nov 2022, suggesting a decline in the company's total economic value.
-21.05%

Market Cap vs. Enterprise Value

A higher enterprise value growth rate compared to market cap growth could indicate that the company is investing heavily in growth initiatives or taking on more debt.
EV Growth > Market Cap Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (27 periods), accounting for compounding effects.
-19.46%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (27 periods), accounting for compounding effects.
-17.31%